Skip to main content
OpenTrials

Clinical trial condition

Hepatitis B, Chronic

Explore clinical trials studying Hepatitis B, Chronic. Study availability and eligibility vary by location and protocol.

162 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis B, Chronic trial results

Active, not recruiting

Effectiveness of Antiviral Treatment in Cirrhotic Patients with Low-level Hepatitis B Virus DNA Levels

NCT04780204

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Kyungpook National University Hospital Daegu, South Korea
  • Asan Medical Center Seoul, South Korea
  • Chung-Ang University Hospital Seoul, South Korea
  • Konkuk University Hospital Seoul, South Korea
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB).

NCT06550128

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Mengchao Hepatobiliary Hospital of Fujian Medical University Fuzhou, Fujian, China
  • The third People's Hospital of Zhenjiang Zhenjiang, Jiangsu, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, China
  • The Second Affiliated Hospital of Chongqing Medical University Chongqing, China
View Trial Details
Completed

Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic Hepatitis B Virus (HBV) Infection

NCT04749368

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Investigative Site 61002 Kingswood, New South Wales, Australia
  • Investigative Site 61001 Westmead, New South Wales, Australia
  • Investigative Site 61004 Herston, Queensland, Australia
  • Investigative Site 88602 Changhua, Taiwan, China
View all 28 locations
View Trial Details
Completed

Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2)

NCT05630820

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • GSK Investigational Site Centreville, Alabama, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site San Francisco, California, United States
View all 171 locations
View Trial Details
Completed

Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1)

NCT05630807

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site Davis, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Palo Alto, California, United States
View all 177 locations
View Trial Details
Completed

Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection

NCT04856085

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Investigative Site San Francisco, California, United States
  • Investigative Site Miami, Florida, United States
  • Investigative Site Orlando, Florida, United States
  • Investigative Site Baltimore, Maryland, United States
View all 37 locations
View Trial Details
Completed

A Study on the Safety, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide Against Chronic Hepatitis B (CHB) and Chronic Hepatitis B Targeted Immunotherapy (CHB-TI) in CHB Patients Receiving Nucleos(t)Ide Analogue (NA) Therapy

NCT05276297

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Edegem, Belgium
  • GSK Investigational Site Sliven, Bulgaria
  • GSK Investigational Site Sofia, Bulgaria
  • GSK Investigational Site Sofia, Bulgaria
View all 51 locations
View Trial Details

Related conditions